Studying DNA fragments in stomach cancer tissue
Part of Cancer, Digestive system clinical trials.
This trial looks at tiny pieces of DNA found outside cells in stomach tissue to better understand how gastric (stomach) cancer starts and progresses. It may help future patients by improving how doctors study stomach cancer from biopsy and surgical samples.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You are planning a stomach scope (gastroscopy) or stomach surgery for gastric adenocarcinoma (stomach cancer)
- Your doctor believes you need a biopsy sample to confirm the diagnosis
- Your stomach biopsy or tissue shows at least two of these: non-atrophic gastritis, atrophic gastritis, intestinal metaplasia, abnormal growth (low/high grade intraepithelial neoplasia), or gastric adenocarcinoma
- You can and will sign consent to let the study use your tissue samples for later research
- You are not pregnant or breastfeeding, and you have no serious uncontrolled illnesses or other major cancers
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for people with stomach discomfort who are coming to this hospital for an endoscopy. Researchers will use the test results to help catch stomach cancer early and keep an eye on it after surgery.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This study monitors people after surgery for gastric cancer. It checks how patients recover and helps doctors learn more about the condition. You can join if you have stomach discomfort and are receiving care at the gastric surgery clinic of this center.
This study looks for early warning changes in the stomach and aims to improve early detection and prevention. Depending on your situation, you may be grouped as having stomach symptoms, early lesions that might be removed, already-diagnosed stomach cancer, or a comparison group without stomach problems.
This study looks for metabolic markers in your blood and tumor tissue to help find stomach cancer early, predict your prognosis, and watch for recurrence. If you qualify, you would give blood and tumor samples for testing.
This study looks for a blood “signature” that can spot early, risky stomach changes (before cancer) and stomach cancer. It may help clinicians diagnose earlier and decide who needs closer follow-up.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.